Arctic Vision and Santen Ink Deal for ARVN001 Commercialization in China
CompanyDeals

Arctic Vision and Santen Ink Deal for ARVN001 Commercialization in China

Pfizer Considers Sale of Hospital Unit Amid Pressure from Starboard Value
Company

Pfizer Considers Sale of Hospital Unit Amid Pressure from Starboard Value

FibroGen Inc. Reports 15% YOY Revenue Growth in Q3 2024 Led by Evrenzo
Company

FibroGen Inc. Reports 15% YOY Revenue Growth in Q3 2024 Led by Evrenzo

AstraZeneca Inc. Reports 21% YOY Revenue Growth in Q3 2024 Financials
Company

AstraZeneca Inc. Reports 21% YOY Revenue Growth in Q3 2024 Financials

BeiGene's Q3 2024 Results Show 28% YOY Revenue Growth Driven by Brukinsa and Tevimbra
Company

BeiGene’s Q3 2024 Results Show 28% YOY Revenue Growth Driven by Brukinsa and Tevimbra

Bayer AG Posts Modest Q3 Growth with Strong Performance from New Pharmaceuticals
Company

Bayer AG Posts Modest Q3 Growth with Strong Performance from New Pharmaceuticals

Sunshine Lake Pharma Inks Licensing Deal with Apollo Therapeutics for APL-18881
CompanyDeals

Sunshine Lake Pharma Inks Licensing Deal with Apollo Therapeutics for APL-18881

Sihuan Pharmaceutical Plans IPO for Xuanzhu Biopharm on Hong Kong Stock Exchange
CompanyDeals

Sihuan Pharmaceutical Plans IPO for Xuanzhu Biopharm on Hong Kong Stock Exchange

Boehringer Ingelheim Joins MTM Vision Consortium to Advance Diabetes Retinopathy Research
CompanyDeals

Boehringer Ingelheim Joins MTM Vision Consortium to Advance Diabetes Retinopathy Research

J&J MedTech Receives FDA IDE for OTTAVA Robotic Surgical System Trials
CompanyMedical Device

J&J MedTech Receives FDA IDE for OTTAVA Robotic Surgical System Trials

Zai Lab Ltd Reports 46% YOY Revenue Growth in Q3 2024 Driven by Vygart, Zejula, and Nuzyra
Company

Zai Lab Ltd Reports 46% YOY Revenue Growth in Q3 2024 Driven by Vygart, Zejula, and Nuzyra

Legend Biotech's Q3 Revenue Soars 67% YOY Driven by Carvykti Sales
Company

Legend Biotech’s Q3 Revenue Soars 67% YOY Driven by Carvykti Sales